A Study of Patient Continued Use of Topical Medications as Prescribed for Treatment of Chronic Rhinosinusitis

Overview

About this study

The purpose of this study is to use pharmacy data to identify patient use patterns of prescribed topical medications for chronic rhinosinusitis, and then survey the patients who are not complying for the difficulties they feel prevent use.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria

Physician diagnosed Chronic Rhinosinusitis for at least 6 months
Has prescribed topical treatment for Chronic Rhinosinusitis (other than saline) for the past 6 months

Exclusion Criteria

Are only on saline topical therapy
Without a physician diagnosis for at least 6 months
On topical medications for less than 6 months

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Scottsdale/Phoenix, Ariz. Mayo Clinic principal investigator Matthew Rank, M.D.	Closed for enrollment

Mayo Clinic Location

Status

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Matthew Rank, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials